Splicing mutation of the TP53 gene in hepatocellular carcinoma

Authors

  • Khurelsukh Buyanbat Laboratory of Molecular biology, Institute of Biology, Mongolian Academy of Sciences, Ulaanbaatar, Mongolia https://orcid.org/0000-0003-2441-6118
  • Ariya Enkhtuya Laboratory of Molecular biology, Institute of Biology, Mongolian Academy of Sciences, Ulaanbaatar, Mongolia
  • Nomuun Oyunbat Laboratory of Molecular biology, Institute of Biology, Mongolian Academy of Sciences, Ulaanbaatar, Mongolia
  • Zolzaya Sandag Laboratory of Molecular biology, Institute of Biology, Mongolian Academy of Sciences, Ulaanbaatar, Mongolia
  • Tuul Boldbaatar Laboratory of Molecular biology, Institute of Biology, Mongolian Academy of Sciences, Ulaanbaatar, Mongolia
  • Maral Davaanyam Laboratory of Molecular biology, Institute of Biology, Mongolian Academy of Sciences, Ulaanbaatar, Mongolia
  • Nomin Bold Laboratory of Molecular biology, Institute of Biology, Mongolian Academy of Sciences, Ulaanbaatar, Mongolia
  • Ankhbayar Enkhbaatar Department of General Surgery, Second State Central Hospital, Ulaanbaatar, Mongolia
  • Gan-Erdene Baatarjav Department of General Surgery, Second State Central Hospital, Ulaanbaatar, Mongolia
  • Taivan Nanzaddorj Department of General Surgery, Second State Central Hospital, Ulaanbaatar, Mongolia
  • Oyunsuren Tsendsuren Laboratory of Molecular biology, Institute of Biology, Mongolian Academy of Sciences, Ulaanbaatar, Mongolia
  • Gantulga Davaakhuu Laboratory of Molecular biology, Institute of Biology, Mongolian Academy of Sciences, Ulaanbaatar, Mongolia

Keywords:

mRNA, TP53, mutation, tumor

Abstract

The tumor suppressor gene TP53 participates in the important regulations and activities of the cell such as cell cycle, apoptosis, repairing damage of DNA and gene expression and its mutation occurs at a higher rate in most tumor cases. When mutation of gene TP53 occurs, protein p53 loses its function leading to increase in the probability of unregulated division of abnormal cells. We studied mutations of the TP53 gene in operation samples of liver cells of patients diagnosed with hepatocellular carcinoma. In order to do this, total RNA molecules were isolated from liver tissue samples of the patients and exon 4 to exon 11 of TP53 gene were amplified by using polymerase chain reaction. Interestingly, a mutation occurred in sample number T30 during synthesis of the TP53 gene, where an intron 7 was not spliced. In the sample T30, intron 7 was not spliced due to deletion of sequence section responsible for recognition and binding at the 5’ spliceosome. Therefore, a reading frame of the protein is altered and a stop codon is appeared at the intron resulting in disruption in the synthesis of the protein p53, which lead to protein deficiency and a weakness of regulation against the tumor in the cell that may have caused carcinoma.

Элэгний хорт хавдрын эсэд үүссэн ТР53 генийн сплайсинг мутаци

Хураангуй: Хавдар дарангуйлагч TP53 ген нь эсийн мөчлөг, апоптоз, ДНХ-ийн гэмтлийг засах, генийн экспресс зэрэг эсийн чухал зохицуулгууд, үйл ажиллагаанд оролцдог бөгөөд уг генийн мутаци ихэнх хорт хавдрын үед өндөр давтамжтай тохиолддог. TP53 генд мутаци үүсэх үед р53 уураг нь үүргээ алдаж хэвийн бус эсүүд зохицуулагагүйгээр хуваагдах магадлал ихэснэ. Бид элэгний хорт хавдар оноштой хүний хавдрын эсэд TP53 генийн мутацийн судалгаа хийв. Үүний тулд элэгний эдээс нийт РНХ молекул ялгаж улмаар TP53 генийн 4-11-р экзоны хэсгийг полимеразын гинжин урвал (ПГУ)-аар олшруулан судалгаанд ашигласан. Судалгааны дүнд 1 дээжид (Т30 дугаартай) TP53 генийн нийлэгжлийн явцад интрон 7 нь сплайсингид ороогүй мутаци илэрсэн. Тухайлбал, 7-р интроны 5’сплайсом таньж холбогдох дараалал бүхий хэсэг делецид орсон тул уг интроны сплайсинг явагдаагүй байна. Үүний улмаас уургийн уншигдах хүрээнд өөрчлөлт орж уг интроны хэсэгт зогс кодон илэрснээр р53 уураг бүрэн нийлэгжээгүй тул уг уургийн хэмжээ багасч эсийн хавдрын эсрэг зохицуулга суларч хавдар үүссэн байж болзошгүй юм.

Түлхүүр үгс: мРНХ, TP53, мутаци, хавдар

Abstract
9
PDF
7

Downloads

Published

2021-10-26

How to Cite

[1]
K. Buyanbat, “Splicing mutation of the TP53 gene in hepatocellular carcinoma”, Proc. Inst. Biol., vol. 37, no. 1, Oct. 2021, doi: 10.5564/pib.v37i1.3141.

Issue

Section

Articles

How to Cite

[1]
K. Buyanbat, “Splicing mutation of the TP53 gene in hepatocellular carcinoma”, Proc. Inst. Biol., vol. 37, no. 1, Oct. 2021, doi: 10.5564/pib.v37i1.3141.

Most read articles by the same author(s)